Dysregulated expression of the homeobox gene, HOX11 is a frequent etiologic event in T-cell acute lymphoblastic leukemias. HOX11-transgenic mice (IgHl-HOX11 Tg )-expressing HOX11 in the B-cell compartment develop B-cell lymphomas with extended latency. The latency suggests that additional genetic events are required prior to the onset of malignant lymphoma. We report the identification of 17 HOX11 collaborating genes, revealed through their propensity to be targeted in a proviral insertional mutagenesis screen. Seven integrations disrupted genes in mitotic spindle checkpoint control, suggesting that cells with elevated HOX11 expression are especially sensitive to dysregulation of chromosome segregation during mitosis. IgHl-HOX11
Dysregulated expression of the homeobox gene, HOX11 is a frequent etiologic event in T-cell acute lymphoblastic leukemias. HOX11-transgenic mice (IgHl-HOX11 Tg )-expressing HOX11 in the B-cell compartment develop B-cell lymphomas with extended latency. The latency suggests that additional genetic events are required prior to the onset of malignant lymphoma. We report the identification of 17 HOX11 collaborating genes, revealed through their propensity to be targeted in a proviral insertional mutagenesis screen. Seven integrations disrupted genes in mitotic spindle checkpoint control, suggesting that cells with elevated HOX11 expression are especially sensitive to dysregulation of chromosome segregation during mitosis. IgHl-HOX11
Tg primary B-lymphocyte cultures exposed to the aneugenic agents, colchicine and colcemid, exhibited increased incidences of chromosome missegregation as assessed by cytokinesisblock micronucleus assays. Additionally, IgHl-HOX11 Tg cultures were shown to exhibit aberrant bypass of spindle checkpoint arrest, as assessed by the increased presence of cycling cells determined by assessment of DNA content and by BrdU immunolabelling. Western immunoblotting revealed elevated expression of the mitotic effector molecules, cyclin A, cyclin B1 and cdc20 in IgHl-HOX11 Tg cultures. Moreover, spontaneously arising lymphoid neoplasms in IgHl-HOX11 Tg mice frequently exhibit aberrant expression of mitotic regulators, concomitant with increased development of micronuclei, abnormal mitotic checkpoint control and increased incidences of abnormal karyotypes when expanded in culture. Collectively, these findings indicate that abnormal regulation ofIntroduction Dysregulated expression of the orphan homeobox gene, HOX11 is a frequent etiologic event in pediatric T-cell acute lymphoblastic leukemias (T-ALLs). Aberrant activation of HOX11 can be achieved by a t(10;14)(q24;q11) chromosome rearrangement, juxtaposing the HOX11 gene downstream of the T-cell receptor (TCR) a/d regulatory elements (Dube´et al., 1986 (Dube´et al., , 1991 . While the t(10;14) translocation is seen in only 4-7% of reported T-ALL cases, a recent study revealed elevated HOX11 expression levels in leukemic blasts in B50% (37/76) of pediatric T-ALL cases (Kees et al., 2003) . Moreover, an additional 30% of pediatric T-ALLs exhibited inappropriate activation of the related HOX11 gene, HOX11L2 (Mauvieux et al., 2002) . Clinically, patients with HOX11-positive lymphoblasts have a better prognosis when treated with modern combination chemotherapy than patients with T-ALLs involving activation of HOX11L2 (Ferrando et al., 2002 (Ferrando et al., , 2004 . The incidence of HOX11-positive lymphomas correlates with increasing age, indicating a longer latency for disease manifestation and suggesting the requirement of additional genetic events prior to malignancy (Asnafi et al., 2004) .
Early attempts at generating clinically relevant mouse models of HOX11-related disease by using the Lck proximal promoter to drive expression of HOX11 during early stages of thymocyte development were unsuccessful and resulted in embryonic lethality. The first in vivo model of HOX11-associated lymphomagenesis was generated by ectopically expressing HOX11 in the B-cell compartment by placing the transgene under the control of the immunoglobulin heavy chain (IgH) promoter and enhancer sequences. Within 2 years, HOX11-transgenic mice (IgHm-HOX11 Tg ) developed mature marginal zone B-cell lymphomas, originating in the spleen with frequent dissemination of lymphomatous tissue to distant sites, including the thymus, lymph nodes, lungs and kidneys (Hough et al., 1998) . These mice represented a relevant model of B-lymphoma disease progression in which to develop immunotherapies (Rosic-Kablar et al., 2000) . Moreover, the extended latency prior to the development of lymphoma indicated that additional genetic events were necessary prior to the onset of malignancy, and therefore, these mice represented a powerful system in which to identify genetic pathways underlying the pathogenesis of HOX11-mediated lymphomagenesis.
Retroviral insertional mutagenesis in mice is a powerful approach for the identification of genes that participate in tumorigenesis. It is particularly useful for the identification of genes that are downstream, cooperating events in multistep malignant transformation processes (Berns, 1991; Jonkers and Berns, 1996) . Inoculation of transgenic mice with slow, nononcogenebearing retroviruses results in disease acceleration by random proviral insertions within the host genome and subsequent disruption of adjacent genomic regions. Retroviral-derived DNA sequences that integrate adjacent to cellular oncogenes or within coding regions of tumor suppressors, can result in altered host gene expression contributing, ultimately, to clonal expansion of the infected cell. While the proviral tagging approach has resulted in the discovery of many genes involved in lymphoid and myeloid leukemias (Li et al., 1999; Hwang et al., 2002; Kim et al., 2003; Erkeland et al., 2004; Iwasaki et al., 2004; Shin et al., 2004) , less work has been conducted on mature B-cell lymphomas.
In this report, we employ a novel approach to identify genes that collaborate with HOX11 in tumorigenesis in a mature B-lymphocyte target population by using the Du5H murine AIDS (mAIDS) virus (Aziz et al., 1989; Chattopadhyay et al., 1989) (Huang et al., 1991 (Huang et al., , 1995 . In one study, inoculation of susceptible C57BL6/J mice with helper-free stocks of Du5H mAIDS virus identified two common integration sites, Dis-1 and Dis-2, in 20 and 13% of infected mice, respectively (Huang et al., 1995) . This approach, when applied to IgHm-HOX11 Tg animals, resulted in the identification of 17 HOX11 collaborating genes, revealed through their propensity to be targeted by the Du5H mAIDS virus during clonal expansion. The identified provirally tagged genes collectively intimate a mechanism for HOX11-mediated oncogenesis, whereby elevated HOX11 expression leads to enhanced sensitivity to dysregulation of segregation of genetic material during mitosis and increased susceptibility for the development of aneuploidies, a prelude to transformation.
Results

C57BL6/J IgHm-HOX11
Tg mice develop mature B-cell malignancies with delayed latency We have previously reported that IgHm-HOX11 Tg mice bred on a CD1 genetic background develop marginal zone B-cell malignancies with extended latency (Hough et al., 1998) , indicating the necessity of additional genetic lesions to cooperate with HOX11 in the oncogenic process. Attempts to accelerate B-cell lymphoma in these mice by infection of neonates with the Moloney murine leukemia virus (MMLV) were unsuccessful, as all mice injected with the virus developed T-cell lymphomas at B3 months postinjection, with no effects on the B-cell compartment (Thy1 þ population in spleen: 68.9% in wild type versus 67.9% in IgHm-HOX11 Tg mice, n ¼ 6) (Table S1 in Supplementary Information). This lack of effect was likely due to the preference of the MMLV to target early thymocyte progenitors.
An alternative novel approach of utilizing the Du5H mAIDS virus as an insertional mutagen was developed given the virus preference for infecting mature B-cells (Huang et al., 1989 (Huang et al., , 1991 . However, mutagenesis studies in the CD1 IgHm-HOX11 Tg mice using the Du5H mAIDS virus were hampered by the decreased susceptibility of CD1 mice to infection with the Du5H mAIDS virus (Huang et al., 1992) . To overcome this difficulty, the CD1 IgHm-HOX11 Tg mice were backcrossed with C57BL6/J mice for >20 generation to give rise to heterozygous IgHm-HOX11 Tg mice on a mAIDS-susceptible, inbred C57BL6/J genetic background. To confirm that this line of C57BL6/J IgHm-HOX11 Tg mice (hereafter referred to as the IgHm-HOX11 Tg mice) also developed B-cell malignancies, a cohort of 25 IgHm-HOX11 Tg mice together with a control cohort of 25 age-and sex-matched C57BL6/J control littermates were followed for 24 months. At the end of this period, all but one of the control mice were healthy, whereas 60% (15/25) of the IgHm-HOX11 Tg mice had developed mature B-cell malignancies. The median age of disease onset for the 15 affected mice was 603 days (Figure 1a , blue curve). The latency period was longer and the penetrance lower than that seen with IgHm-HOX11 Tg mice on a CD1 genetic background (>80% developed marginal zone lymphomas by B420 days), indicating strain-specific variability in disease penetrance and presentation.
Histological examination of a spectrum of tissues, including bone marrow, spleen, thymus, lymph nodes, kidney, liver and lungs from the 15 diseased mice indicated that the IgHm-HOX11
Tg developed a lymphomatous disease, with the spleen being the principal organ involved. Normal splenic follicular architecture was disrupted, with extensive expansion of the germinal center and infiltration of the white pulp into the surrounding red pulp (Figure 1b) . The lymphoma cells were a relatively uniform population of large pleomorphic centroblasts characterized by prominent nuclear membranes with 1-2 inconspicuous nucleoli surrounded by a small rim of cytoplasm. Mediastinal involvement was seen in 13% (2/15) of diseased mice, with the mediastinal masses comprised of neoplastic lymphocytes with a similar phenotype as those described in the spleen. Numerous mitotic figures and apoptotic debris in the form of tingible body macrophages were also seen within the tumor. Immunohistochemical staining of tumor sections with B220 antibodies indicated the presence of a high proportion of strongly positive B220 þ cells. Other organs frequently exhibiting lymphomatous infiltrates were the liver, lung and kidney (Figure 1b) . Flow cytometric analyses of age-and sex-matched control and IgHm-HOX11 Tg mice revealed normal thymocyte subpopulations in C57BL6/J mice, whereas thymuses infiltrated with lymphoma cells were profoundly abnormal, often showing increased numbers of CD4
À
CD8
À double-negative subpopulation and an accompanying increase in B220 þ cells (Figure 1c ). Lymphoma cells expressed both IgM and IgD, indicating they were mature B-cells. These findings are consistent with our previous observations that the target cell for transformation by HOX11 in IgHm-HOX11 Tg mice is not an early stage lymphocyte originating in the marrow but rather a mature, peripheral B-cell, and indicate a diagnosis of a germinal center-derived diffuse large B-cell lymphoma based on the Bethesda proposal for classification of lymphoid neoplasms in mice (Morse et al., 2002) .
Du5H mAIDS virus accelerates B-cell malignancies in IgHm-HOX11
Tg mice To identify genes associated with accelerated disease development in IgHm-HOX11 Tg mice, 10 38-day-old C57BL6/J and 10 IgHm-HOX11 Tg mice were each inoculated with 1 ml of a helper-free stock of the Du5H strain of the mAIDS virus. Histological examination demonstrated that, while mAIDS-injected C57BL6/J animals possessed an intact follicular architecture in the spleen, mAIDS-injected IgHm-HOX11 Tg mice spleens were characterized by expanded white pulp regions comprised of pleomorphic centroblasts reminiscent of the phenotype seen in IgHm-
HOX11
Tg mice described in Figure 1 . Thymic involvement was seen in 100% (9/9) of the mAIDS-injected IgHm-HOX11
Tg studied, and bone marrow cellularity also appeared to be increased in the IgHm-HOX11 Tg mice ( Figure 2c ). Flow cytometric analyses of thymuses isolated from the mAIDS-injected IgHm-HOX11 Tg animals revealed a high percentage (62%) of cells staining negatively for the T-cell markers CD4 and CD8, and positively for the B-cell markers, B220 (56%), and IgM and IgD (30%) (Figure 2d ). The cell surface immunophenotyping results shown are representative of four examined animals (Table 1) . Additionally, thymic tumors isolated from mAIDS-infected IgHm-HOX11 Tg mice exhibited elevated expression of bcl6, CD10 and CD23 ( Figure S1 in Supplementary Information), a gene 
Virus integration sites in Du5H-induced lymphomas
To isolate virus-host junction DNA fragments, inverse PCR (IPCR) was applied to the panel of nine Du5H-induced spleens and thymic tumors isolated from inoculated animals exhibiting accelerated disease. Host flanking genomic sequences in the IPCR-generated amplicons were determined by sequencing from nested primers in long terminal repeat (LTR) sequences of the viral genome. Analysis of a small portion of the LTR in the obtained sequence included the requisite deletion of 2 bp at the end of the viral LTRs confirming that the amplified fragments were derived from bona fide proviral integration sites. Preliminary IPCR screens were performed on splenic B-cells and resulted in the identification of 37 different retroviral integration sites (RISs). Given the heterogeneity of the B-cell population in the spleen, IPCR screens were repeated on the thymic tumors in order to identify integration events which were biased towards genes whose disruption were capable of leading to clonal expansion and formation of a tumor at a distant site. In theory, these targets would represent particularly crucial collaborators in the HOX11-mediated tumorigenesis process. Using this process, 17 RISs were corroborated and reproduced in the nine thymic tumors analysed (Table 2 and Table S2 in Supplementary Information). Eight integrations were found to match with known integration sites in the Mouse Retroviral Tagged Cancer Gene Database (MRTCGD) (Akagi et al., 2004) . Most (13/17) of the RISs were situated flanking transcriptional units, whereas a minority (4/17) were situated within coding regions of genes.
Of the 17 RISs, seven fell near or within genes known to participate in regulation of chromosome segregation (Ubr1, Mad1l1, Bub3, Aurka, Pim1, Cmt2a, Cse1l ). Quantitative real-time RT-PCR (qPCR) was used to validate differential expression of the seven genes. Invariably, tumor cells exhibiting a proviral insertion flanking a gene exhibited upregulation of the target mRNA transcripts, while tumors with a proviral insertion within a gene exhibited downregulation of the target transcript (Figure 3a ). Differential expression of Aurka transcripts in mouse 188 and Cmt2a transcripts in mouse 649 was detected by qPCR without the identification of a corresponding integration site by the IPCR screen. These differential gene expressions may reflect alternative mechanisms by which gene expression was altered during oncogenesis or may represent cases in which proviral insertions were missed by our screen. There were no significant fluctuations in expression of the phospho-Histone H3 (pH3) mitotic marker in the samples as determined by Western immunoblotting, indicating that the differential expression profiles of the mitotic regulators examined were not due to differences in the mitotic fraction within the tumor samples (Figure 3b ).
HOX11 overexpression confers increased sensitivity to aneugenic stress
The identification of several genes that participate in the regulation of sister chromatid segregation as proviral targets suggested that HOX11-overexpressing cells may possess an increased susceptibility to chromosome segregation errors. To test this theory, primary B-cell cultures were initiated from IgHm-HOX11
Tg animals and treated with spindle toxins which destabilize microtubules, prevent the formation of spindle fibers and perturb chromosome segregation during anaphase (Bourner et al., 1998) . Chromosome missegregation events following exposure to low doses of colchicine and colcemid were determined by the cytokinesis-block The mechanism by which HOX11 overexpression confers a heightened susceptibility to aneuploidy following introduction of aneugenic insults may be associated with the ability of HOX11 to potentiate bypass of aneugen-induced spindle checkpoint arrest, allowing for chromosome missegregation. This hypothesis was supported by analysis of B-cell numbers in culture following nos. 177, 179, 180, 188, 644, 645, 647, 649 and 653) and one thymic tumor from one Du5H-infected C57BL6/J animal (no. 175). Fold changes are expressed relative to the Du5H-infected C57BL6/J control (no. 175), which was arbitrarily designated as 1.00. Note the log scale. Each qPCR reaction was performed in triplicate and standardized to a B220 internal control. Tumor samples with retroviral integrations at each loci are indicated with an asterisk(*).
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E Chen et al colchicine and colcemid treatment after 24 h. Although not statistically significant, control cultures appeared to exhibit a mild decline in cell numbers with increasing levels of colchicine and colcemid whereas the IgHm-HOX11 Tg B-cell cultures were not affected (Figure 4d ). One possible explanation is that the wild-type cultures were being subjected to a cell cycle arrest during mitosis through an activation of the spindle assembly checkpoint that was being ignored in the IgHm-HOX11 Tg cultures. To investigate this theory, control and IgHm-HOX11 Tg B-cell cultures were synchronized by a double thymidine block for 48 h, released into 50 ng/ml colchicine for 16 h, and mitotic cells were quantified at various time points by DNA content analysis. Whereas control lymphocytes exhibited a prolonged mitotic arrest between 16-24 h with increased numbers of cells containing a tetraploid (4n) complement of DNA, IgHm-HOX11 Tg B-cells more rapidly bypassed this arrest (Figure 5a ). The ability of HOX11-overexpressing B-lymphocytes to resume cell cycle notwithstanding spindle checkpoint arrest was further verified by BrdU labelling to quantitate levels of cycling cells 24 h following release into colchicine. In these corroborative studies, we detected a statistically significant increase in BrdU-positive B-lymphocytes in IgHm-HOX11
Tg cultures relative to wild-type cultures (43.2 versus 28.4%, P ¼ 0.015) (Figure 5b ). The ability of IgHm-HOX11 Tg cells to aberrantly bypass mitotic arrest may be associated with its ability to facilitate the upregulation of key effector mitotic proteins. Western immunoblot analysis revealed upregulation of cyclin A, cyclin B1, and cdc20, a subunit of the anaphase-promoting complex, in IgHm-HOX11 Tg B-lymphocytes relative to control lymphocytes (Figure 5c ). Levels of the G1/S checkpoint effector protein, cyclin D2, and housekeeping proteins, gp94 and b-actin, were unaltered. Taken 
Deregulated expression of mitotic reglators during lymphomagenesis in IgHm-HOX11
Tg mice To assess the relevance of deregulated expression of these genes in HOX11-mediated B-cell lymphomagenesis, their expression profiles were assessed on a panel of 10 spontaneously arising B-cell malignancies derived from IgHm-HOX11 Tg mice. Real-time qPCR performed on purified B220 þ splenocytes from moribund mice revealed frequent misregulation of expression of the Aurka, Bub3, Pim1, Cse1l and Ubr1 gene products during the evolution of spontaneous malignancies (Figure 6a) . Importantly, deregulated expression of most of the genes occurred in a mutually exclusive manner in the tumors (Figure 6b ). The lone exception was Ubr1, in which loss of expression was always detected in conjunction with disrupted expression of other genes, suggesting that loss of Ubr1 in conjunction with deregulated HOX11 expression alone is insufficient for malignancy and requires yet more genetic lesions. Again, the differential expression profiles did not correlate with fluctuations in the mitotic fraction in the tumors as determined by expression of the pH3 mitotic marker (Figure 6c) .
Four tumor samples (Tumor nos. 2-4 and 6) were expanded ex vivo for further analysis. Wild-type and Tg (tg B) mice. A total of 10 independent lymphomatous samples are represented by gray boxes. Fold changes are expressed relative to the wild-type B-lymphocyte sample, which was arbitrarily designated as 1.00. Note the log scale. Each qPCR reaction was performed in triplicate and standardized to a B220 internal control. (b) Schematic representation of gene expression changes. Red boxes indicate elevated expression, blue boxes indicate diminished expression, yellow boxes indicate no effect.
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IgHm-HOX11 Tg B-lymphocyte cultures derived from 1 to 2 month, pre-malignant mice were initiated in parallel as control cultures. In the absence of exogenous aneugenic stress, tumor nos. 3, 4 and 6 exhibited statistically significant increases in micronuclei formation following 4 days in culture (Po0.05) when compared to the wild-type or IgHm-HOX11 Tg B-cell cultures (Figure 7a ). Cultures derived from tumor no. 2 also exhibited an increase in micronuclei formation, although the trend was not statistically significant (P ¼ 0.16). The lack of significant micronuclei formation in IgHm-HOX11 Tg B-cell cultures in these experiments (in conjunction with the lack of increase of micronuclei formation at the untreated data point in Figure 4d ) confirms that HOX11 by itself appears to be unable to cause missegregation of chromosomes but merely confers an increased susceptibility to segregation errors in the presence of additional aneugenic insults. However, that the HOX11-expressing tumors inherently possessed increased chromosome segregation errors led us to investigate whether the tumor cells also exhibited a similar propensity to bypass mitotic arrest, similar to the 
IgHm-HOX11
Tg B-cells. Therefore, double thymidineblocked tumor cultures were released into colchicine, and the mitotic fractions were assessed by quantitation of cells with a tetraploid (4n) complement of DNA and by flow cytometric detection of the pH3 mitotic marker. Both methods reiterated the tendency of IgHm-HOX11 Tg B lymphocytes to bypass mitotic arrest as evidenced by the more rapid decline of mitotic cells at the 18 h time point relative to wild-type B-lymphocyte cultures (compare dashed lines in Figures 7b and c) . Moreover, tumor cultures were found to behave similarly with the IgHm-HOX11 Tg B-lymphocyte cultures and similarly exhibited a tendency to bypass mitotic arrest (solid lines in Figure 7b and c). To determine whether the mitotic defects of the tumor cells were associated with abnormal karyotypes, the extent of aneuploidy was determined using a flow cytometric method for detection of numerical chromosomal aberrations (Muehlbauer and Schuler, 2005) , in addition to preparation of chromosome spreads and counting of chromosome numbers. In both cases, increased percentages of mitotic cells exhibiting hyperdiploid and polyploid karyotypes were observed in the four tumor samples (Figure 7d and e). Representative spreads are shown in Figure 7f . Therefore, spontaneously arising tumors in IgHm-HOX11 Tg mice have similar characteristics as IgHm-HOX11 Tg B-lymphocyte cultures exposed to exogeneous aneugenic stress, including increased micronuclei formation and abnormal mitotic checkpoint control, ultimately culminating in the development of aneuploid karyotypes.
Discussion
In this study, we used a novel approach to identify disease genes involved in the pathogenesis of mature B-cell malignancies that occur in transgenic mice expressing the HOX11 oncoprotein by performing in vivo retroviral mutagenesis using helper-free stocks of the Du5H mAIDS virus. In contrast to other studies using the MMLV or in the AKXD or BXH2 inbred mouse lines to accelerate pre-T and pre-B lymphomas or myeloid leukemias (Li et al., 1999; Hwang et al., 2002; Kim et al., 2003; Erkeland et al., 2004; Iwasaki et al., 2004; Shin et al., 2004) , this approach exploited the preferential tropism of the mAIDS virus for mature B lymphocytes and successfully accelerated cancer progression in IgHm-HOX11 Tg mice. The relatively low number of integrations observed (B1.9 per tumor) is consistent with reports that the Du5H mAIDS virus yields fewer (between 2 and 4) integration events when compared to MMLV (between 6 and 10) or with other models of recombinant inbred mouse strains characterized by laterally transmitted retroviruses (Huang et al., 1995) . The fewer integration events observed in each tumor likely reflects the limited progenitor activity of the target cell population of the Du5H mAIDS virus as well as the age at which the inoculations are administered. Whereas, retroviruses are transmitted laterally in the breast milk of AKXD and BXH2 mouse lines and MMLV infections are typically conducted on newborn pups, Du5H mAIDS inoculations are performed on 30-to 40-day-old pups in order to target a more mature B-cell. The limited lifespan of the mature B-cell target population likely increases the probability of clonal extinction prior to the development of malignancy.
In our viral screen using IgHm-HOX11 Tg mice, the preponderance of targets (7/17 or 41%) involving genes that play a role in the regulation of chromosome segregation suggests genes belonging to this functional group represent especially relevant oncogenic targets in HOX11-associated B-cell lymphomagenesis pathways. In particular, of the seven RISs identified, integration within the coding region of the Ubr1 gene was seen in three independent animals and represented the most commonly identified of the RISs. The Ubr1 gene encodes a member of the E3 ubiquitin ligase family of proteins, responsible for facilitating the direct ubiquitination of substrate proteins as a mechanism for designating proteins destined for proteosomal degradation (Varshavsky, 1996) . Recent evidence has demonstrated a role for the Ubr1 gene product in the degradation of the SCC1 component of cohesin, a multiprotein complex responsible for regulating chromosome segregation during anaphase. Ubr1-null Saccharomyces cerevisiae mutants possess a long-lived SCC1 protein and consequently exhibit loss of fidelity of chromosome maintenance with increased incidences of chromosome loss and aneuploidy (Rao et al., 2001) . Studies aimed at elucidating the synergistic cooperativity between these two genes in B-cell lymphomagenesis revealed elevated incidences of chromosome missegregation in IgHm-HOX11
Tg
/Ubr1
À/À primary B-lymphocyte cultures and increased incidences of aneuploid karyotypes relative to Ubr1 À/À cells (manuscript submitted). Such subsequent validation studies demonstrate the relevance of the targets identified in insertional mutagenesis screens, and highlight the usefulness of the Du5H mAIDS virus as a tool in similar types of studies in other mature B-cell lymphoma models.
It is interesting to note that HOX11 overexpression, by itself, does not appear to be sufficient in conferring abnormal chromosome segregation, and that the elicitation of missegregation errors is dependent on the introduction of either an exogenous aneugenic stressor such as the microtubule-destabilizing drugs, colchicine or colcemid, or an accompanying genetic alteration in crucial mitotic spindle checkpoint genes. The stochastic nature of oncogenesis underlying HOX11-overexpressing malignancies may account for the incomplete penetrance of the disease phenotype seen not only in the IgHm-HOX11 Tg mice, but also in the clinic where unaffected individuals with a t(10;14)(q24;q11) translocation have been identified (Lichty et al., 1995) . Additionally, when HOX11-associated lymphomas do develop, it is invariably associated with an extended latency in IgHm-HOX11 Tg mice as well as in diagnosed human T-ALLs (Ferrando et al., 2004) . The prolonged delay prior to disease development likely reflects the need for the HOX11-overexpressing cell to overcome two obstacles to achieve transformation: (1) to acquire an additional mutation in a gene-regulating chromosome segregation, and (2) to acquire sufficient chromosome abnormalities to be cancer promoting. However, another implication of this disease mechanism is the expectation that HOX11 þ cancers would be especially sensitive to high doses of spindle poisons, which should promote catastrophic chromosomal abnormalities and induce cell death. Indeed, relative to other T-ALL subtypes, HOX11
þ T-ALLs have been demonstrated to be exceedingly responsive to combination chemotherapies (Asnafi et al., 2004; Ferrando et al., 2004) , which typically employ spindle poisons in the treatment regimen. It may also explain the refractory nature of relapsed HOX11
þ T-ALLs to chemotherapy, which likely possess a complex karyotype, and the resultant need for bone marrow transplantation therapy for second-line treatment (Asnafi et al., 2005) .
HOX11 overexpression has previously been implicated in aberrant regulation of both G1/S progression (Riz and Hawley, 2005) in addition to transition into mitosis (Kawabe et al., 1997) . Specifically, overexpression of HOX11 in Jurkat T-lymphocyte cell lines leads to aberrant bypass of G2/M arrest induced by ionizing radiation (Kawabe et al., 1997) . These dual functions of HOX11 mirror those of another transcription factor, FoxM1, a forkhead box transcription factor, recently shown to be required for proper mitotic spindle checkpoint function and chromosome stability (Laoukili et al., 2005) . Altered expression of FoxM1 in U2O2 cancer cells led to defects in chromosome alignment and abnormal progression through mitosis. Comparable to FoxM1, HOX11-overexpression also leads to aberrant spindle checkpoint control, bypass of mitotic arrest and chromosome missegregation, leading ultimately to karyotypic abnormalities and cellular transformation. Thus, the current report represents the first demonstration of a homeobox transcription factor in a similar disease paradigm, and should provide new avenues of investigation into understanding the molecular mechanisms by which HOX11 functions to induce lymphocyte transformation.
Materials and methods
Du5H mAIDS-induced lymphomas
IgHm-HOX11
Tg mice, originally developed in the CD1 genetic background, were backcrossed with C57BL6/J mice for >20 generation to give heterozygous IgHm-HOX11 Tg mice on a C57BL6/J background. Wild-type and IgHm-HOX11 Tg mice were maintained in the animal facility of the Sunnybrook and Women's College Health Sciences Centre and housed under pathogen-free conditions in microisolators. For Du5H mAIDS inoculation, 10 control and 10 IgHm-HOX11 Tg mice, aged 38 days, were inoculated twice intraperitoneally with helperfree stocks of the Du5H mAIDS virus. Inoculations were performed with 1 ml of viral extracts at a 7-day interval. When moribund, mice were killed, and spleen, thymus, lymph node and tumor tissues were harvested. PCR analysis of the Du5H provirus, and the Du5H and b-actin transcripts were performed as previously described (Casabianca et al., 2003) .
Inverse PCR
Inverse-PCR analysis of flanking genomic regions was performed as previously described (Li et al., 1999) . The mAIDS-specific primers used were MAIDS-FW: TACTTCC TTGTTCTTGTTTT; MAIDS-RV: TCAACCCCAAGCCT CATTTA. PCR products were purified using the QiaEXII glass milk purification kit (QIAGEN, Mississauga, ON, Canada), and directly sequenced at the Core Molecular Biology Facility at York University, Toronto, Canada.
Real-time qPCR
Trizol-extracted RNA was reverse transcribed into cDNA using the SuperScript II First-Strand cDNA Synthesis Kit (Invitrogen) according to manufacturer's protocols. Reverse transcription reactions were diluted to 50 ml, and 2 ml of the diluted reaction mixture was used for qPCR amplification using the QuantiTect SYBR Green PCR kit (QIAGEN) according to manufacturer's protocols. The primers used for the qPCR reaction were as follows: CSE1LF: ATGGAGT CCTTCGTACAGCGCA; CSE1LR: CCAGATAGCTGTGA CAAAGCGA; CMT2AF: AGGAACCTTCCAATCCTGCG GA; CMT2AR: AGAAGTCTCGTAGGTGACTGAG; BUB3F: GGTCTACACCCTGTCAGTGTCT; BUB3R: GTGGCACT TGAAGGCGTACTTG; AURKAF: CAGAAGAATGAG CAGCCTGCAG; AURKAR: CTGTTCCAAGGGGCGCA TATTC; MAD1L1F: ACTCCACTGCGTCAAACCTCTC; MAD1L1R: CTCTTGTGTGCACGAGGACTGT; PIM1F: GATAGTTTCGTGCTGATCCTGG; PIM1R: GTAGACTG TGTCCTTGAGCAGC; B220F: GCTATGATCTGCGCAA GAAAAG; B220R: CTTTCGGGCATCTTTGATGGGA. Thermocycling conditions were an initial denaturation step at 941C for 15 min, followed by 32 cycles of 941C for 30 s, 601C for 30 s and 721C for 1 min in an ABI Prism 7000 Real Time Thermocycler.
Primary B-lymphocyte cultures B-lymphocytes were isolated from 1-to 3-month-old mice (for primary B-lymphocyte cultures) or from moribund mouse spleens (for primary tumor cultures) by disruption of whole spleen tissues through a 40 mm nylon cell strainer. Cells were treated with 0.165 M NH 4 Cl-Tris for 15 min to lyse erythrocytes. Primary B-lymphocytes were isolated using the MACS magnetic bead sorting system (Miltenyi Biotech, Auburn, CA, USA), according to manufacturer's instructions. Flow cytometric analysis of purified cells indicated a purity of B-cells of >90%. Purified B220 þ B-lymphocytes were maintained at a cell density of 2 Â 10 6 cells per ml in DMEM supplemented with 20% FCS, 2 mM L-glutamine, 1% penicillin/streptomycin, 0.05% anti-CD40 antibody and 10 ng/ml recombinant murine interleukin-4. Media change was performed 48 h after initiation of cultures.
CBMN assays
Day 4 primary B-lymphocyte cultures were treated with various concentrations of colchicine or colcemid in conjunction with 3 mg/ml cytochalasin B for 16 h. Cells were collected by centrifugation at 1000 rpm for 10 min, washed once in Carnoy's fixative (3:1 methanol:glacial acetic acid), and resuspended in Carnoy's fixative at B100 000 cells per ml. Approximately 10 drops of the cell suspension were dropped onto a horizontally held slide, and the slides were air dried for 1 h at room temperature. Slides were stained with 10 mg/ml acridine orange for 2 min, followed by two washes with dH 2 O.
Stained slides were scored under fluorescent microscopy. For each independent culture, 200 binucleated cells were scored.
Bromodeoxyridine (BrdU) labelling and immunocytochemistry To induce mitotic arrest, day 3 primary B-lymphocyte cultures were treated with 50 ng/ml colchicine overnight. BrdU was added to a final concentration of 10 mM and incubated at 371C for 2 h. B-lymphocytes were then collected by centrifugation at 1000 r.p.m. for 10 min and fixed in Carnoy's fixative, followed by DNA denaturation in 2 M HCl for 1 h at 371C. Cells were pretreated by incubation with PBS supplemented with 3% bovine serum albumin for 2 h at 371C. Immunostaining was performed using an anti-BrdU antibody (Stressgen, Victoria, BC, Canada) at a dilution of 1:100 for 2 h at 371C, followed by staining with a FITC-conjugated anti-mouse antibody (Stressgen) at a dilution of 1:500 for 1 h at 371C. Slides were evaluated using fluorescence microscopy. In all, 10 random fields were scored for BrdU positivity.
DNA Content and pH3 analysis
For DNA content, day 2 primary B-lymphocyte cultures were subjected to a double-thymidine block, and released into 50 ng/ml colchicine. Cells were processed for DNA content determination or pH3 immunostaining as previously described (Diamond and DeMaggio, 2000; Muehlbauer and Schuler, 2005) . For each sample, 10 000-30 000 events were acquired on a FACSCalibur flow cytometer, and cell cycle distributions were performed using the Modfit software.
Ploidy analysis
Detection of numerical aberrations in mitotic cells using a dual DNA content/pH3 immunostaining approach by flow cytometry was described previously (Muehlbauer and Schuler, 2005) . Preparation of chromosome spreads from cultures was described previously (Dube´et al., 1986) .
Immunoblotting analysis
Proteins were separated on SDS-PAGE, blotted to nitrocellulose membrane, and probed at various dilutions with a primary antibody recognizing HOX11 (1:2000), Wt1 (1:200), cyclin D2 (1:200), cyclin B1 (1:200), cyclin A (1:500), cdc20 (1:200), gp94 (1:1000), pH3 (Ser10) (2 mg/ml) or b-actin (1:3000) for 4 h at room temperature, followed by three washes with PBST for 20 min each. Membranes were subsequently incubated with either anti-mouse (1:10 000) or anti-rabbit (1:10 000) antibody conjugated to horseradish peroxidase for 1 h at room temperature. The Wt1 antibody was obtained from Novus Biologicals, the gp94 antibody was obtained from Stressgen, the anti-pH3 antibody was obtained from Upstate, the b-actin antibody was obtained from Sigma, and all other antibodies were obtained from Santa Cruz Biotechnologies (Santa Cruz, CA, USA).
